Monday, June 27, 2016 1:40:13 PM
On the contrary, the facts show otherwise.
There is little attempt to get out of debt. Instead, the amount of debt is INCREASING. He is also defrauding the State of Washington with unpaid taxes, which is why CoroWare has been sued by the State multiple times in the last several years. He also announced an illegal share repurchase plan, which was solely for stock promotion purposes to allow the toxic death spiral convertible holders the ability to dump more stock onto brand new bagholders who were scammed by the announcement of the illegal buyback. Instead of using those funds to pay down the debt, which any honest and half-way intelligent CEO would have done, he instead repurchased stock at a price 400% of what the shares were issued for the DAY BEFORE, and then those exact same shares went right back out the door THE NEXT DAY at a price 25% of what he repurchased them for. Please explain how that "gets the company out of debt".
Is that what an honest CEO does? No. And honest CEO's also file their legally required regulatory documents on-time, something that COWI has done only about 10% of the time.
Recent COWI News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/01/2023 09:20:45 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 09:47:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 12:30:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/22/2023 07:13:47 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:00:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 12:35:32 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 07/17/2023 02:06:52 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 06/28/2023 06:46:02 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM